SMAD2 and Hepatic fibrosis: TGF-β is the primary profibrogenic factor initiating liver fibrosis events, through the activation of HSC trans-differentiation accompanied by the stimulation of downstream signaling pathways including Smad3/4, while inhibiting regulatory networks such as Smad2/7, which promotes fibrotic lesions progression [47].